{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:09:00Z","timestamp":1788815340863,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002573","name":"Yonsei University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002573","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.nmd.2026.106491","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T01:15:09Z","timestamp":1784855709000},"page":"106491","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Differential expression of microRNAs and other small RNAs in the serum of patients with myotonic dystrophy type 1 and facioscapulohumeral muscular dystrophy type 1"],"prefix":"10.1016","volume":"66","author":[{"given":"Yoonjung","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3161-9899","authenticated-orcid":false,"given":"Soo-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sojin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunjung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Chul","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-A","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4165-8901","authenticated-orcid":false,"given":"Hyung Jun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.nmd.2026.106491_bib0001","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000524734","article-title":"Global prevalence of myotonic dystrophy: an updated systematic review and meta-analysis","volume":"56","author":"Liao","year":"2022","journal-title":"Neuroepidemiology"},{"issue":"3","key":"10.1016\/j.nmd.2026.106491_bib0002","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000444018","article-title":"An age-standardized prevalence estimate and a sex and age distribution of myotonic dystrophy types 1 and 2 in the Rome province, Italy","volume":"46","author":"Vanacore","year":"2016","journal-title":"Neuroepidemiology"},{"issue":"4","key":"10.1016\/j.nmd.2026.106491_bib0003","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.nmd.2022.03.003","article-title":"Serum miRNAs as biomarkers for the rare types of muscular dystrophy","volume":"32","author":"Koutsoulidou","year":"2022","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.1016\/j.nmd.2026.106491_bib0004","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/15476286.2022.2058817","article-title":"Circulating small RNA signatures differentiate accurately the subtypes of muscular dystrophies: small-RNA next-generation sequencing analytics and functional insights","volume":"19","author":"Kakouri","year":"2022","journal-title":"RNa Biol"},{"issue":"12","key":"10.1016\/j.nmd.2026.106491_bib0005","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1212\/WNL.0000000000000797","article-title":"Population-based incidence and prevalence of facioscapulohumeral dystrophy","volume":"83","author":"Deenen","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2026.106491_bib0006","article-title":"Prevalence and disease progression of genetically-confirmed facioscapulohumeral muscular dystrophy type 1 (FSHD1) in China between 2001 and 2020: a nationwide population-based study","volume":"18","author":"Wang","year":"2022","journal-title":"Lancet Reg Health West Pac"},{"issue":"2","key":"10.1016\/j.nmd.2026.106491_bib0007","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.nmd.2026.106491_bib0008","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"issue":"7216","key":"10.1016\/j.nmd.2026.106491_bib0009","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/nature07299","article-title":"MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation","volume":"455","author":"Tay","year":"2008","journal-title":"Nature"},{"issue":"6078","key":"10.1016\/j.nmd.2026.106491_bib0010","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1126\/science.1215691","article-title":"miRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay","volume":"336","author":"Djuranovic","year":"2012","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.nmd.2026.106491_bib0011","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3390\/ijms21020561","article-title":"Challenges in using circulating micro-RNAs as biomarkers for cardiovascular diseases","volume":"21","author":"Felekkis","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"17","key":"10.1016\/j.nmd.2026.106491_bib0012","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1111\/jcmm.17462","article-title":"MicroRNAs as serum biomarkers in Becker muscular dystrophy","volume":"26","author":"Gagliardi","year":"2022","journal-title":"J Cell Mol Med"},{"issue":"2","key":"10.1016\/j.nmd.2026.106491_bib0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167969","article-title":"Stability of circulating blood-based MicroRNAs - pre-analytic methodological considerations","volume":"12","author":"Glinge","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.nmd.2026.106491_bib0014","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1373\/clinchem.2010.157198","article-title":"Analysis of circulating microRNA: preanalytical and analytical challenges","volume":"57","author":"McDonald","year":"2011","journal-title":"Clin Chem"},{"issue":"6","key":"10.1016\/j.nmd.2026.106491_bib0015","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jmoldx.2013.07.005","article-title":"Quantification of circulating miRNAs in plasma: effect of preanalytical and analytical parameters on their isolation and stability","volume":"15","author":"Sourvinou","year":"2013","journal-title":"J Mol Diagn"},{"issue":"22","key":"10.1016\/j.nmd.2026.106491_bib0016","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20225600","article-title":"MicroRNA-based therapeutic perspectives in myotonic dystrophy","volume":"20","author":"L\u00f3pez Castel","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.nmd.2026.106491_bib0017","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.nmd.2014.02.005","article-title":"Plasma microRNAs as biomarkers for myotonic dystrophy type 1","volume":"24","author":"Perfetti","year":"2014","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.1016\/j.nmd.2026.106491_bib0018","doi-asserted-by":"crossref","DOI":"10.1038\/srep38174","article-title":"Validation of plasma microRNAs as biomarkers for myotonic dystrophy type 1","volume":"6","author":"Perfetti","year":"2016","journal-title":"Sci Rep"},{"issue":"D1","key":"10.1016\/j.nmd.2026.106491_bib0019","doi-asserted-by":"crossref","first-page":"D155","DOI":"10.1093\/nar\/gky1141","article-title":"from microRNA sequences to function","volume":"47","author":"Kozomara","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"10.1016\/j.nmd.2026.106491_bib0020","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1093\/nar\/gks042","article-title":"Differential expression analysis of multifactor RNA-seq experiments with respect to biological variation","volume":"40","author":"McCarthy","year":"2012","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"10.1016\/j.nmd.2026.106491_bib0021","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.3390\/jcm9123939","article-title":"The biomarker potential of miRNAs in myotonic dystrophy type I","volume":"9","author":"Koehorst","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.nmd.2026.106491_bib0022","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.omtm.2021.09.007","article-title":"miR-223-3p and miR-24-3p as novel serum-based biomarkers for myotonic dystrophy type 1","volume":"23","author":"Koutalianos","year":"2021","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"49","key":"10.1016\/j.nmd.2026.106491_bib0023","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2406998121","article-title":"Early disruption of the CREB pathway drives dendritic morphological alterations in FTD\/ALS cortical neurons","volume":"121","author":"Jean Gregoire","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"19","key":"10.1016\/j.nmd.2026.106491_bib0024","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1093\/hmg\/ddy245","article-title":"Pharmacological and physiological activation of AMPK improves the spliceopathy in DM1 mouse muscles","volume":"27","author":"Ravel-Chapuis","year":"2018","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.nmd.2026.106491_bib0025","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.3390\/ijms24043091","article-title":"Protein phosphorylation alterations in myotonic dystrophy type 1: a systematic review","volume":"24","author":"Costa","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.nmd.2026.106491_bib0026","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12968-021-00812-6","article-title":"Progressive myocardial injury in myotonic dystrophy type II and facioscapulohumeral muscular dystrophy 1: a cardiovascular magnetic resonance follow-up study","volume":"23","author":"Blaszczyk","year":"2021","journal-title":"J Cardiovasc Magn Reson"},{"issue":"1","key":"10.1016\/j.nmd.2026.106491_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000007039","article-title":"Cardiac involvement in primary myopathies","volume":"94","author":"Finsterer","year":"2000","journal-title":"Cardiology"},{"issue":"6","key":"10.1016\/j.nmd.2026.106491_bib0028","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2459\/JCM.0000000000001476","article-title":"Cardiac magnetic resonance findings and prognosis in type 1 myotonic dystrophy","volume":"24","author":"Leali","year":"2023","journal-title":"J Cardiovasc Med"},{"key":"10.1016\/j.nmd.2026.106491_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2024.132070","article-title":"Natural history of cardiac involvement in myotonic dystrophy type 1 - emphasis on the need for lifelong follow-up","volume":"406","author":"Petri","year":"2024","journal-title":"Int J Cardiol"},{"issue":"21","key":"10.1016\/j.nmd.2026.106491_bib0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111874","article-title":"Cardiac pathology in myotonic dystrophy type 1","volume":"22","author":"Mahadevan","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nmd.2026.106491_bib0031","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.668180","article-title":"Cardiac involvement in facioscapulohumeral muscular dystrophy (FSHD)","volume":"12","author":"Ducharme-Smith","year":"2021","journal-title":"Front Neurol"},{"issue":"2","key":"10.1016\/j.nmd.2026.106491_bib0032","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.nmd.2008.11.011","article-title":"Facioscapulohumeral muscular dystrophy presenting with hypertrophic cardiomyopathy: a case study","volume":"19","author":"Tsuji","year":"2009","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2026.106491_bib0033","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jns.2016.07.036","article-title":"Renal dysfunction can be a common complication in patients with myotonic dystrophy 1","volume":"368","author":"Matsumura","year":"2016","journal-title":"J Neurol Sci"},{"issue":"1","key":"10.1016\/j.nmd.2026.106491_bib0034","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1038\/s41467-025-56479-5","article-title":"Analysis of human urinary extracellular vesicles reveals disordered renal metabolism in myotonic dystrophy type 1","volume":"16","author":"Kumari","year":"2025","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.nmd.2026.106491_bib0035","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/cdd.2010.164","article-title":"MicroRNA miR-885-5p targets CDK2 and MCM5, activates p53 and inhibits proliferation and survival","volume":"18","author":"Afanasyeva","year":"2011","journal-title":"Cell Death Differ"},{"issue":"10","key":"10.1016\/j.nmd.2026.106491_bib0036","doi-asserted-by":"crossref","DOI":"10.1002\/iub.70068","article-title":"MyomiRs expression in limb girdle muscular dystrophy","volume":"77","author":"Breveglieri","year":"2025","journal-title":"IUBMB Life"},{"issue":"13","key":"10.1016\/j.nmd.2026.106491_bib0037","doi-asserted-by":"crossref","first-page":"8419","DOI":"10.1167\/iovs.15-18036","article-title":"MicroRNA-483-3p inhibits extracellular matrix production by targeting Smad4 in Human trabecular meshwork cells","volume":"56","author":"Shen","year":"2015","journal-title":"Invest Ophthalmol Visual Sci"},{"issue":"2","key":"10.1016\/j.nmd.2026.106491_bib0038","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00441-025-03985-z","article-title":"Hsa-MiR-483 -3p regulates the extracellular matrix proteins via TGF\u03b22\/SMAD4 signaling in the glucocorticoid-responsive human trabecular meshwork cells","volume":"401","author":"Haribalaganesh","year":"2025","journal-title":"Cell Tissue Res"},{"issue":"14","key":"10.1016\/j.nmd.2026.106491_bib0039","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1080\/15384101.2022.2054245","article-title":"MiR-1306-5p predicts favorable prognosis and inhibits proliferation, migration, and invasion of colorectal cancer cells via PI3K\/AKT\/mTOR pathway","volume":"21","author":"Wang","year":"2022","journal-title":"Cell Cycle"},{"issue":"7","key":"10.1016\/j.nmd.2026.106491_bib0040","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.tips.2012.04.003","article-title":"Crosstalk between TGF-\u03b2 signaling and the microRNA machinery","volume":"33","author":"Butz","year":"2012","journal-title":"Trends Pharmacol Sci"},{"issue":"6","key":"10.1016\/j.nmd.2026.106491_bib0041","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/CIRCGENETICS.110.957415","article-title":"Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease","volume":"3","author":"Corsten","year":"2010","journal-title":"Circ Cardiovasc Genet"},{"issue":"2","key":"10.1016\/j.nmd.2026.106491_bib0042","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.18632\/aging.205474","article-title":"The role of miR-6884-5p in epithelial-mesenchymal transition in non-small cell lung cancer","volume":"16","author":"Zhang","year":"2024","journal-title":"Aging"},{"issue":"21","key":"10.1016\/j.nmd.2026.106491_bib0043","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111568","article-title":"Non-coding RNAs as regulators of myogenesis and postexercise muscle regeneration","volume":"22","author":"Archacka","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.nmd.2026.106491_bib0044","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.molcel.2013.08.027","article-title":"The imprinted H19 lncRNA antagonizes let-7 microRNAs","volume":"52","author":"Kallen","year":"2013","journal-title":"Mol Cell"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896626001598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896626001598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:45:30Z","timestamp":1788813930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896626001598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":44,"alternative-id":["S0960896626001598"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2026.106491","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential expression of microRNAs and other small RNAs in the serum of patients with myotonic dystrophy type 1 and facioscapulohumeral muscular dystrophy type 1","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2026.106491","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106491"}}